View in EDS HTML Full Text PDF Full Text

To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?.

Saved in:

Bibliographic Details
Title:	To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?.
Authors:	Ollier, Laurence¹ (AUTHOR), Monte, Anne De¹ (AUTHOR), Thibault, Vincent² (AUTHOR), Pugliese, Pascal³ (AUTHOR), Chirio, David³ (AUTHOR), Durant, Jacques³ (AUTHOR), Carles, Michel^3,4 (AUTHOR), Naqvi, Alissa³ (AUTHOR)
Source:	Open Forum Infectious Diseases. Jun2025, Vol. 12 Issue 6, p1-4. 4p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	23288957
DOI:	10.1093/ofid/ofaf266